NERI, Matteo
 Distribuzione geografica
Continente #
NA - Nord America 7.439
EU - Europa 5.680
AS - Asia 5.297
SA - Sud America 715
AF - Africa 90
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 11
Totale 19.258
Nazione #
US - Stati Uniti d'America 7.291
SG - Singapore 2.112
CN - Cina 1.486
IT - Italia 1.029
IE - Irlanda 803
UA - Ucraina 801
RU - Federazione Russa 650
BR - Brasile 598
TR - Turchia 559
SE - Svezia 552
GB - Regno Unito 525
VN - Vietnam 512
DE - Germania 490
FR - Francia 363
IN - India 243
FI - Finlandia 223
CA - Canada 75
HK - Hong Kong 71
PL - Polonia 51
BD - Bangladesh 50
MX - Messico 50
AR - Argentina 48
AT - Austria 37
JP - Giappone 33
KR - Corea 33
ID - Indonesia 29
IQ - Iraq 29
CZ - Repubblica Ceca 27
ZA - Sudafrica 27
AU - Australia 26
NL - Olanda 25
ES - Italia 21
PK - Pakistan 20
VE - Venezuela 20
BE - Belgio 19
EC - Ecuador 18
TW - Taiwan 17
MA - Marocco 16
GR - Grecia 15
SA - Arabia Saudita 14
CO - Colombia 12
KE - Kenya 11
IR - Iran 10
IL - Israele 9
PH - Filippine 9
TN - Tunisia 9
JO - Giordania 8
EU - Europa 7
AL - Albania 6
DZ - Algeria 6
EE - Estonia 6
EG - Egitto 6
KG - Kirghizistan 6
UZ - Uzbekistan 6
ET - Etiopia 5
PY - Paraguay 5
RO - Romania 5
RS - Serbia 5
SV - El Salvador 5
JM - Giamaica 4
KZ - Kazakistan 4
MY - Malesia 4
NO - Norvegia 4
OM - Oman 4
PE - Perù 4
AZ - Azerbaigian 3
BH - Bahrain 3
CH - Svizzera 3
CL - Cile 3
DO - Repubblica Dominicana 3
GE - Georgia 3
LT - Lituania 3
MD - Moldavia 3
PS - Palestinian Territory 3
PT - Portogallo 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
BB - Barbados 2
BG - Bulgaria 2
BO - Bolivia 2
DK - Danimarca 2
GA - Gabon 2
GY - Guiana 2
HN - Honduras 2
HR - Croazia 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
NG - Nigeria 2
NP - Nepal 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TH - Thailandia 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
BF - Burkina Faso 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
Totale 19.243
Città #
Singapore 1.539
Jacksonville 957
Chandler 876
San Jose 808
Dublin 798
Ashburn 507
Chieti 494
Princeton 389
Dallas 375
Beijing 372
Southend 354
Izmir 305
Nanjing 266
Dearborn 198
Wilmington 165
Munich 164
Cambridge 156
Ho Chi Minh City 152
Altamura 151
Los Angeles 146
Santa Clara 144
Tongling 118
Nanchang 113
The Dalles 107
Ann Arbor 104
Hanoi 97
New York 91
Buffalo 86
Dong Ket 74
Boardman 73
Hong Kong 65
Moscow 65
Helsinki 61
Kunming 58
Shenyang 56
Redondo Beach 55
Woodbridge 49
Orem 48
São Paulo 48
Council Bluffs 44
Jiaxing 43
Tianjin 39
Hebei 35
Houston 34
Chicago 33
Montreal 33
Washington 33
Hefei 30
Chennai 29
Tokyo 27
Norwalk 26
Warsaw 26
Da Nang 25
Frankfurt am Main 25
London 25
Brooklyn 24
Denver 24
Manchester 23
Nuremberg 23
Seattle 23
Vienna 23
Atlanta 22
Grevenbroich 22
Stockholm 22
San Francisco 21
Milan 20
Pescara 20
Changsha 19
Hangzhou 19
Rio de Janeiro 19
Seoul 19
Toronto 19
Brussels 18
Haiphong 17
Johannesburg 17
Düsseldorf 16
Falls Church 16
Hsinchu 16
Poplar 16
Augusta 15
Brno 15
Mexico City 14
Rome 14
Guangzhou 13
Mumbai 13
Segrate 12
Amsterdam 11
Baghdad 11
Belo Horizonte 11
Brasília 11
Messina 11
Olomouc 11
Pune 11
Turku 11
Wroclaw 11
Boston 10
Brisbane 10
Dhaka 10
Kocaeli 10
Lanzhou 10
Totale 11.914
Nome #
Developing a Decision-making Model Based on an Interdisciplinary Oncological Care Group for the Management of Colorectal Cancer 272
100 CLASSIFICAZIONI IN GASTROENTEROLOGIA 203
Genome-wide analysis of 53,400 people with irritable bowel syndrome highlights shared genetic pathways with mood and anxiety disorders 190
An explorative study identifies miRNA signatures for the diagnosis of non-celiac wheat sensitivity 189
13C Breath tests and cytosolic liver function. 187
An exploratory gene expression study of the intestinal mucosa of patients with non-celiac wheat sensitivity 186
Wnt gene expression in polyposis and colorectal cancer 185
Visceral and somatic hypersensitivity in patients with the irritable bowel syndrome (IBS) 168
Absence of Helicobacter pylori in tonsillar swabs from dyspeptic patients. 166
Visceral sensitivity and symptoms in patients with constipation of diarrhea-predominant irritable bowel syndrome (IBS) 161
Genetic alterations of Wnt pathways in familial versus sporadic polyps 156
Angiodysplasia of the small bowel: a possible cause of anemia even in mild chronic renal failure 151
Amiodarone inhibits tocopherol-mediated human lipoprotein peroxidation 149
Sensitivity disturbances in patients with irritable bowel syndrome and fibromyalgia 148
Application of the Biopsy-Sparing ESPGHAN Guidelines for Celiac Disease Diagnosis in Adults: A Real-Life Study 146
The expression of LEC/CCL16, a powerful inflammatory chemokine, is upregulated in ulcerative colitis. 145
Optimal combination of media for primary isolation of Helicobacter pylori from gastric biopsy specimens. 144
Antioxidant properties of ursodeoxycholic acid 143
Helicobacter pylori infection causes persistent platelet activation in vivo through enhanced lipid peroxidation 142
A multicentre case control study on complicated coeliac disease: two different patterns of natural history, two different prognoses 141
Obscure and occult gastrointestinal bleeding: comparison of different imaging modalities. 141
Accuracy of flagella’s staining in the diagnosis of Helicobacter pylori infection: comparative study with the hystology, culture, and rapid urease test. 141
Detection of Helicobacter pylori by PCR on gastric biopsy specimens taken for CP test: comparison with histopathological analysis. 138
Anticoagulants and antiplatelet agents in patients undergoing polypectomy 138
A prospective evaluation of iron deficiency anemia in the GI endoscopy setting: role of standard endoscopy, videocapsule endoscopy, and CT-enteroclysis 137
Cardiovascular outcome in treated hypertensive patients with responder, masked, false resistant, and true resistant hypertension. 137
Symptoms discriminate irritable bowel syndrome from organic gastrointestinal diseases and food allergy. 136
Evolutionarily-Related Helicobacter pylori Genotypes and Gastric Intraepithelial Neoplasia in a High-Risk Area of Northern Italy 135
La dispepsia 133
Association of body iron stores with low molecular weight iron and oxidant damage of human atherosclerotic plaques 133
Aumentati livelli mucosali gastrici di IL-1alfa, IL-6 ed IL-8 in pazienti Helicobacter pylori-positivi affetti da cardiopatia ischemica. 131
GENE EXPRESSION SIGNATURES DIFFERENTIATE NON-CELIAC GLUTEN SENSITIVITY FROM CELIAC DISEASE PATIENTS AND CONTROLS AND MAY POTENTIALLY CONTRIBUTE TO DISEASE DIAGNOSIS 131
The black esophagus 129
Radiochemotherapy in Anal Cancer: cCR, clinical outcomes and quality of life using two different treatment schedules 128
Circulating Extracellular Vesicles Are Increased in Newly Diagnosed Celiac Disease Patients 127
Glutathione-related enzyme activities and lipoperoxide levels in human internal mammary artery and ascending aorta. Relations with serum lipids 127
Prevalence and clinical characteristics of refractoriness to optimal proton pump inhibitor therapy in non-erosive reflux disease 126
Comparison of the E test to agar dilution and broth microdilution methods for quantitative antimicrobial susceptibility testing of Helicobacter pylori. 124
A serologic survey of Helicobacter pylori infection in 3281 Italian patients endoscoped for upper gastrointestinal symptoms. The Italian Helicobacter Pylori Study Group. 122
Cardiovascular and renal events in uncomplicated mild hypertensive patients with sustained and white coat hypertension 122
Gastrointestinal manifestations of SARS-CoV-2 infection in an Italian population of hospitalized patients 122
C-Urea Breath Test for Helicobacter pylori Infection: Stability of Samples over Time 121
Visceral and somatic hypersensitivity in patients with Irritable Bowel Syndrome (IBS) 121
Iron deficiency anemia despite effective gluten-free diet in celiac disease: Diagnostic role of small bowel capsule endoscopy 121
Increased Prevalence of Rare Sucrase-isomaltase (SI) Pathogenic Variants in Irritable Bowel Syndrome Patients 120
Loss-of-function of the Voltage-Gated Sodium Channel NaV1.5 (Channelopathies) in Patients With Irritable Bowel Syndrome 119
Usefulness of Leifson staining method in diagnosis of Helicobacter pylori infection. 119
Eosinophilic esophagitis is a component of the anticonvulsant hypersensitivity syndrome: Description of two cases. 118
GENE EXPRESSION SIGNATURES CAN POTENTIALLY CONTRIBUTE TO THE DIAGNOSIS OF NON-CELIAC GLUTEN SENSITIVITY 118
Wireless capsule endoscopy in the diagnostic of small intestine angiodysplasia in chronic uremic patient 117
In vitro activity of clarithromycin against intracellular Helicobacter pylori. 117
Effect of cholinergic agonists and antagonists on gallbladder volume in fasting man. 117
Gastric adenomas: relationship between clinicopathological findings, Helicobacter pylori infection, APC mutations and COX-2 expression 117
L’esofago di barrett 117
Visceral sensitivity and symptoms in patients with constipation- or diarrea-predominant Irritable Bowel Syndrome (IBS): Effect of a low fat intraduodenal infusion. 117
The role of Zinc L-Carnosine in the prevention and treatment of gastrointestinal mucosal disease in humans: a review 117
Influence of the COVID-19 Outbreak on Disease Activity and Quality of Life in Inflammatory Bowel Disease Patients 115
Serum and mucosal cytokine profiles in patients with active Helicobacter pylori and ischemic heart disease: is their a relationship ? 114
Cysteinyl-leukotriene D4 induced IL-1 beta expression ans release in rat vascular smooth muscle cells. 114
Needlestick injuries among obstetrics and gynecology trainees: A study design to investigate an underestimated priority 114
Acute esophageal necrosis: possible association with terlipressin. 114
P Role of the antibiotic sensitivity test before helicobacter pylori eradication treatments in naive patients 113
Contribution of the Leifson stain to the detection of Helicobacter pylori from antral biopsy specimens. 112
Effetti dell’antibiotico-resistenza di H. pylori sulle terapie eradicanti. 111
Prognostic Relevance of Metabolic Syndrome in Hypertensive Patients at Low-to-Medium Risk. 110
A transition clinic model for inflammatory bowel disease between two tertiary care centers: outcomes and predictive factors 110
Spiral and coccoid forms of H. pylori in gastric mucosa biopsies: an electron microscopy study. 110
Ricerca di Helicobacter pylori tramite PCR su biopsie gastriche sottoposte al test rapido all’ureasi (CP-test). 109
Randomised clinical trial: mucosal protection combined with acid suppression in the treatment of non-erosive reflux disease - efficacy of Esoxx, a hyaluronic acid-chondroitin sulphate based bioadhesive formulation. 108
White Paper of Italian Gastroenterology: Delivery of services for digestive diseases in Italy: Weaknesses and strengths. 107
Good isolation of Helicobacter pylori by a new combination of selective and nonselective media. 106
Impact of primary tumor location in patients with RAS wild-type metastatic colon cancer treated with first-line chemotherapy plus anti-EGFR or anti-VEGF monoclonal antibodies: A retrospective multicenter study 106
Approccio diagnostico al sanguinamento gastrointestinale occulto nel paizente in trattamento emodialitico 105
Metabolic syndrome is a risk factor for colorectal adenoma and cancer: a study in a White population using the harmonized criteria 105
Prospective screening of dyspeptic patients by Helicobacter pylori serology: a safe policy? The Italian Helicobacter pylori Study Group. 104
[Physiology of interdigestive motor activity in man]. 103
An inter- and intra-laboratory comparison of breath ¹³CO₂analysis 103
Constipation severity is associated with productivity losses and healthcare utilization in patients with chronic constipation 102
Canine ileocolonic sphincter: flow, transit, and motility before and after sphincterotomy 102
Effect of somatostatin on gallbladder volume and small intestinal motor activity in humans 102
Manifestazioni extraesofagee della malattia da reflusso gastroesofageo 101
S1847 Randomized Controlled Trial of Biofeedback, Electrical Stimulation, and Biofeedback Plus Electrical Stimulation in Patients with Severe Fecal Incontinence After Colo-Anal Anastomosis 101
In vitro activity of clarithromycin against intracellular Helicobacter pylori. 100
The gut microbiota and obesity in humans 100
A modern multidisciplinary approach to the treatment of enterocutaneous fistulas in Crohn’s disease patients 100
Dopamine-induced migrating myoelectrical complex-like activity in human duodenum. 100
Helicobacter pylori antigen stool test and 13C-urea breath test in patients after eradication treatments 99
Inhibitory activity of salicylic acid on lipoxygenase-dependent lipid peroxidation 99
[Effect of domperidone maleate on chronic dyspepsia and gastric emptying]. 99
Comparative study of the effects of cimetropium bromide and atropine on human esophageal motor functions. 98
Has the COVID-19 Pandemic Worsened Health-Related Quality of Life of Patients with Inflammatory Bowel Disease? A Longitudinal Disease Activity-Controlled Study 97
CLINICAL ADVANCES IN GASTRIC FILLING AND EMPTYNG OF LIQUID EVALUED BY REAL-TIME ULTRASONOGRAPHY 97
Celiac disease-like abnormalities in the Irritable bowel syndrome. 96
Stasis syndromes following gastric surgery: clinical and motility features of 60 symptomatic patients. 96
Dopamine interrupts gastrointestinal fed motility pattern in humans. Effect on motilin and somatostatin blood levels. 96
Confirmatory factor analysis of the Patient Assessment of Constipation-Symptoms (PAC-SYM) among patients with chronic constipation 96
Outcome of nonerosive gastro-esophageal reflux disease patients with pathological acid exposure. 95
Motility disorders and stress. 95
Treatment of Helicobacter pylori infection. Triple regimen based on ranitidine bismuth citrate could be solution 95
Visceral sensitivity and symptoms in patients with constipation and diarrhea-predominant irritable bowel syndrome (IBS) 95
Totale 12.460
Categoria #
all - tutte 77.488
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.488


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021271 0 0 0 0 0 0 0 0 0 137 28 106
2021/20221.201 291 28 32 195 73 17 21 69 69 22 86 298
2022/20232.593 229 396 130 301 217 517 169 178 312 29 66 49
2023/20241.205 80 50 77 45 79 357 296 71 5 16 3 126
2024/20253.062 194 485 379 56 79 106 98 167 433 142 320 603
2025/20265.785 503 248 699 825 523 375 1.049 398 684 481 0 0
Totale 19.735